Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | AGN | TEVA | MYL | RDY |
| Company | Cymabay Therapeutics | Allergan Plc | Teva Pharmaceutical Industries ADR | Mylan NV Ord Shs | Dr. Reddy's Laboratories Ltd ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 32.49 | 193.01 | 13.17 | 15.64 | 71.10 |
| High | 32.50 | 193.38 | 13.21 | 16.15 | 71.36 |
| Low | 32.48 | 191.64 | 12.75 | 15.34 | 70.79 |
| Last | 32.48 | 193.02 | 12.78 | 15.86 | 70.91 |
| Change | +0.01 | +0.03 | -0.40 | +0.31 | -0.40 |
| % Change | +0.03% | +0.02% | -3.03% | +1.96% | -0.56% |
| Volume | 8,356,200 | 12,442,600 | 8,957,330 | 26,574,100 | 97,180 |
| 20-Day Average Volume | 3,390,805 | 4,993,145 | 8,941,510 | 8,612,350 | 169,365 |
| Previous Close | 32.47 | 192.99 | 13.18 | 15.55 | 71.31 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | No | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 188.05 | 13.80 | 15.15 | 72.75 |
| 20-Day Raw Stochastic | 94.12% | 76.90% | 1.75% | 86.27% | 3.29% |
| 20-Day Relative Strength | 78.00% | 59.14% | 41.08% | 55.75% | 39.66% |
| Weighted Alpha | +247.60 | +28.20 | +56.51 | -23.10 | +15.21 |
| Today's Opinion | 100% Buy | 72% Buy | 56% Buy | 40% Sell | 24% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 56% Buy | 64% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 88% Buy | 64% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +1.73% since 05/01/20 | -7.86% since 04/11/24 | +4.86% since 11/09/20 | -2.44% since 04/11/24 |
| Low | 32.44 on 03/15/24 | 187.75 on 05/04/20 | 12.75 on 04/18/24 | 15.10 on 11/10/20 | 70.79 on 04/18/24 |
| High | 32.50 on 03/21/24 | 196.45 on 05/06/20 | 13.70 on 04/12/24 | 16.15 on 11/16/20 | 72.39 on 04/12/24 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | +6.59% since 04/08/20 | -4.05% since 03/18/24 | +0.92% since 10/16/20 | -6.07% since 03/18/24 |
| Low | 32.15 on 02/22/24 | 181.21 on 04/09/20 | 12.75 on 04/18/24 | 14.00 on 10/29/20 | 70.79 on 04/18/24 |
| High | 32.50 on 03/21/24 | 196.45 on 05/06/20 | 14.47 on 04/08/24 | 16.15 on 11/16/20 | 74.44 on 04/01/24 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -2.05% since 02/07/20 | +16.29% since 01/18/24 | -2.07% since 08/14/20 | +4.05% since 01/18/24 |
| Low | 22.11 on 01/26/24 | 158.67 on 03/18/20 | 10.86 on 01/19/24 | 14.00 on 10/29/20 | 67.35 on 01/22/24 |
| High | 32.50 on 03/21/24 | 202.21 on 02/12/20 | 14.47 on 04/08/24 | 17.03 on 08/19/20 | 77.72 on 02/23/24 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +6.48% since 11/08/19 | +51.06% since 10/18/23 | +4.58% since 05/15/20 | +4.66% since 10/18/23 |
| Low | 12.32 on 10/13/23 | 158.67 on 03/18/20 | 8.06 on 10/23/23 | 14.00 on 10/29/20 | 63.72 on 11/03/23 |
| High | 32.50 on 03/21/24 | 202.21 on 02/12/20 | 14.47 on 04/08/24 | 19.24 on 06/08/20 | 77.72 on 02/23/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 63,503,972 | 14,776,019 | 8,586,212 | 11,900,070 |
| Shares Outstanding, K | 114,724 | 329,002 | 1,121,094 | 541,546 | 166,878 |
| Annual Sales | 31,070,000 | 16,088,900,000 | 15,846,000,000 | 11,500,500,000 | 2,992,000,000 |
| Annual Net Income | -105,370,000 | -5,271,000,000 | -559,000,000 | 16,800,000 | 548,000,000 |
| Last Quarter Sales | 60,000 | 4,351,000,000 | 4,457,000,000 | 2,972,100,000 | 865,780,000 |
| Last Quarter Net Income | -41,900,000 | -317,200,000 | 429,000,000 | 185,700,000 | 165,470,000 |
| 60-Month Beta | 0.32 | 1.20 | 1.05 | 1.45 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 5.22 on 02/10/20 | 1.00 on 01/31/24 | 0.36 on 11/06/20 | 0.99 on 01/31/24 |
| Latest Earnings Date | 03/21/24 | 05/07/20 | 05/08/24 | 11/06/20 | 05/08/24 |
| Most Recent Dividend | N/A | 0.740 on 04/15/20 | 0.072 on 11/27/17 | 0.060 on 06/27/07 | 0.410 on 07/28/23 |
| Next Ex-Dividends Date | N/A | 04/15/20 | 11/27/17 | N/A | 07/28/23 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.94 | 5.30 | 3.29 | 18.89 |